Join
Live feed
·
INSIDERFilingvia Quantisnow
Mersana Therapeutics Inc. logo

SVP, Chief Sci.&Tech. Officer Lowinger Timothy B sold $27,150 worth of shares (13,687 units at $1.98) and converted options into 50,000 shares, increasing direct ownership by 18% to 235,642 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MRSN· Mersana Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRSN (Mersana Therapeutics Inc.) and more on Quantisnow.